Abstract:
The invention concerns a new composition, typically a dairy fermented composition. The composition can have an improved stability while presenting a low viscosity. It comprised a lactose ingredient, gellan gum, and buttermilk.
Abstract:
A food additive composition including a polyphenol , such as a polyphenol containing product derived from grape seed, apple, pear, green tea or cocoa extracts, in combination with a probiotic, such as a probiotic selected from lactobacilli and bifidobacteria species. A food product or daily food incorporating this food additive. A method of improving cardiovascular health in a subject by administering the food additive composition to the subject.
Abstract:
The present invention relates to a process for preparing a fermented milk product, comprising contacting a milk substrate with an enzyme preparation having exopeptidase activity; contacting a milk substrate with lactic acid bacteria; wherein the lactic acid bacteria have a time to reach a pH of 4.6 of a solution of 12% skimmed milk powder which is at least 30% shorter in the presence 0.5% (w/w) of a yeast extract in the solution of 12% skimmed milk powder than without the presence of the yeast extract in the 12% skimmed milk powder, and wherein said enzyme preparation is a substantially pure exopeptidase preparation. Likewise envisaged is a fermented milk product comprising an enzyme having exopeptidase activity, a kit of parts comprising lactic acid bacteria and enzyme having exopeptidase activity and the use of an exopeptidase for accelerating acidification speed of lactic acid bacteria.
Abstract:
The present disclosure relates to an oral electrolyte solution comprising lactoferrin. Lactoferrin may promote intestinal healing during a bout of diarrhea in a pediatric subject, thereby reducing the duration of diarrhea symptoms. Additionally, the oral electrolyte solutions disclosed herein may comprise Lactobacillus rhamnosus GG, vitamin B 3 and/or a source of zinc. The disclosure further relates to methods of reducing the duration of diarrhea symptoms and reducing gastrointestinal irritation in a pediatric subject by providing an oral electrolyte solution comprising lactoferrin.
Abstract:
The present invention relates to good tasting food products that contain an agent or agents which avoid that taste-essential ingredients having an adverse effect, when digested or when taken up in the system of the consumer, can perform their adverse effects. The said adverse effect is especially an adverse effect on human health. In addition, the present invention relates to particular compounds or compositions that can be used for the directed removal of such adverse components of foods (including drinks).
Abstract:
The present invention provides a Leuconostoc bacterial strain for use in the diary industry to prevent the growth of pathogenic micro-organisms and thereby ensure the quality and safety of milk products produced by fermentation, including cheese, yoghurt, sour cream, buttermilk and kefir products. The Leuconostoc bacterial strain of the invention is a recombinant Leuconostoc carnosum strain, characterised by a lactose-positive phenotype with the ability to utilise lactose as sole carbon source. The invention provides a starter culture comprising the lactose-positive Leuconostoc carnosum of the invention for use in the manufacture of milk products, and milk products prepared with said Leuconostoc strain or said starter culture.
Abstract:
The present invention relates to a method for producing an aqueous protein-containing milk or cream fraction, said method comprising using an enzyme having phospholipase C activity.
Abstract:
The present invention relates to a method of preparing a fermented milk product. The method comprises the steps of treating a milk substrate with a low pH sensitive peptidase and a microorganism, and allowing the treated milk substrate to ferment to produce the fermented milk product.
Abstract:
The present invention relates to compositions for weight management comprising: a) a microbiome modifying component; b) a satiety modifying component; and c) a metabolic modifying component. The composition may also be used for the treatment of obesity, elevated cholesterol, diabetes, hypertension or heart disease.
Abstract:
A process for obtaining increased yields and/or a reduced reaction time in enzymatic conversion of lactose to lactobionic acid comprising adding to a dairy substrate, such as milk, whey or lac-tose solution, a carbohydrate oxidase, capable of converting lactose to lactobionic acid, wherein the process is performed under stable control of pH.